We are excited to announce the presenting companies for the November 14, 2024, VC Fast Pitch:
Tenzr Health presented by Lukas Merhi
- Tenzr Health is gamifying Musculoskeletal Recovery to help Orthopedic Clinics improve patient outcomes and bottom lines.
- Tenzr helps providers extend care beyond the clinic to manage and engage their patients and generate additional revenue via Remote Therapeutic Monitoring CPT reimbursement.
- Tenzr Health’s business model is recurring revenue B2B/SaaS. The company’s early revenue base includes commercial contracts with clinics and major 3rd party companies serving healthcare industries
- Tenzr’s team are experts in quantified health, gaming, wearable technologies, go-to-market in physical medicine (Powerbar, GameReady, AlterG), scaling Healthtech startups. Previous exits include Powerbar (to Nestle), Life Glider and FOTO https://www.tenzrhealth.com
LVED presented by Terry Anderton
LVED was founded by experienced technology entrepreneurs from MIT & UNC responsible for tech exits worth over $500M. This team developed the LVED platform to modernize & democratize estate planning. 80% of the nation’s wealth is held by those 65 & older, yet 50% of people don’t even have a will. The LVED platform makes it easy to create, manage, and execute a comprehensive legal estate plan that is always up to date at a price anyone can afford. https://www.lved.com
The Healthy Aging Company (THAC) presented by Christian Brechot
THAC is a privately-owned biopharmaceutical company which targets age-related diseases and Alzheimer’s diseases, a major unmet medical need.
The company is located both in the United States (University of South Florida, registered in Delaware) and Paris. The executive team offers high level expertise in both science and product development and business. International Key Opinion Leaders are mobilized beside the team, who are FDA and EMEA consultants.
The Company develops ALF-575, a First-In-Class drug candidate with a unique and innovative anti-oxidative mode of action, restoring sensitivity to insulin and acting as a tissue repair and anti-inflammatory molecule. Excellent preclinical results have been obtained which demonstrate blood-brain barrier crossing and significant improvement of cognitive disorders in mouse models of Alzheimer. The preclinical package including results is finalized. The pharmacological properties as well as safety profile have been previously demonstrated in patients with liver diseases. The company is raising five million US dollar to initiate a phase 1/2a clinical study. Return on investment is planned in 2028 (partnering or acquisition). https://www.thac.fr/
Rare Breed Companies presented by Tim McGraw
Rare Breed Companies (RBC) is on a mission to become the first nationally respected brand in natural health and sports nutrition, combining hemp, nootropics, terpenes and functional mushrooms in their highly effective and safe alternatives to dangerous pharmaceuticals. Founder and CEO Tim McGraw’s extensive industry experience, alongside a talented executive team, positions RBC to redefine wellness and fitness through strategic acquisitions and innovative product offerings.
As federal rescheduling progresses (Dec. ’24), RBC plans to acquire state licensed cannabis brands in 8 key states (CA, NJ, OH, FL, IL, CO, NV, AZ). The acquisitions or options on cannabis brands are designed to enhance RBC’s multi-state platform, targeting a $172 billion market. Preparing for potential IPO or sale in 2026. RareBreedCompanies.com
Apriority Financial presented by Tony Willcox
Apriority is making debt as intelligently optimized as investments by analytically assessing $17T of debt through a borrower-first lens. Built by high frequency trading and data science founders, Apriority continually scours rates deploying sophisticated refinance & restructuring analytics on both existing and new loans. Apriority provides active debt management as a service through a B2B2C model which enables recurring revenue, replaces lead-gen inefficiencies, and drives high value at low cost into multiple sectors. Launched in 2023 and raising $1.5M for growth and GTM trials, Apriority is poised to reinvent the mechanics behind the single largest expense in people’s lives. https://apriority.ai/
MeasuredRisk presented by Tom Albert
MeasuredRisk’s revolutionary data insights platform enables leaders to make better business decisions. The Patented technology enables organizations to foresee impending supplier risks that if left unchecked, will lead to business disruption. Our novel approach to identifying impending risks, harnesses the power of unsupervised learning, generating over 3200 risk profiling attributes. We instantly surface supplier risk scores for cyber hygiene and business resilience, while providing alternate supplier lists to ensure organizations are fully optimized. The platform is API driven, scaling to over 1M API calls per hour, meeting the scale demands of the largest, most complex ecosystems in the world. https://measuredrisk.com
Softeq Ventures presented by Chris Howard
Softeq Ventures invests in early-stage technology companies and de-risks them with a unique model of Fund + Venture Studio + Engineering Services.
The Fund powers the Softeq Venture Studio, a unique program that de-risks investments by combining engineering with startup services to help founders build real, scalable, and investable technologies.
Softeq chooses the Top 3% of startups applying to the Studio, provides initial funding, and mentors them in a 4mo Studio program similar to TechStars. Then, it helps them build their POC or MVP, or gets their hardware or software more enterprise-ready, just like Softeq has done for the Fortune 500 for nearly three decades…significantly de-risking the investment. https://www.softeq.com/venture-studio
